AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ESSA Pharma Inc. Director's Dealing 2024

Jan 9, 2024

35249_dirs_2024-01-08_876973ca-38bd-4da5-b013-7f7c8d403c35.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2024-01-05

Reporting Person: Virsik Peter (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-05	Common Shares	S	699	$6.11	Disposed	14022	Direct

Footnotes

F1: The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.